Search Results (11)

The continuously enhanced generative capabilities of artificial intelligence (AI) are challenging the existing patent system. There are still some issues, such as whether AI can be considered an inventor, whether technical solutions generated by AI are patentable, and how ownership should be allocated. AI-generated technical solutions fall under the category of patentable subject matter. Specifically, if they meet the requirements of the “three criteria,” they can become the subject of patent rights. Regarding the issue of AI’s eligibility as an inventor, a parallel technical generation registration system for AI should be established, with the current inventor system maintained in parallel. Concerning patent ownership issues, the assignable subjects of patent rights should be limited to the binary subjects of users and investors. Contractual agreements should take precedence to ensure contractual freedom, and ownership should generally be attributed to the user if no agreement exists. Additionally, a specialized fast-track review and authorization mechanism should be designed for AI-generated technical solutions, given the unique nature of AI-generated solutions. Moreover, their protection periods should be appropriately shortened to ensure a balance of interests. Furthermore, a disclosure system should be built across the entire lifecycle to prevent and mitigate risks that may arise during the machine generation of technical solutions, patent applications, patent authorizations, and dissemination stages. Full article

This review aims to analyze the technological and scientific applications regarding cocoa fermentation through a prospective study of patent documents and research articles. The Espacenet database was used as a patent research tool by searching both the IPC code “A23G1” and the terms “cocoa” and “ferment*”. A total of 130 documents were found—49 were related to the subject. The Scopus database was also searched for scientific articles using the terms “cocoa” and “fermentation”. A total of 812 articles were found—517 were related to the subject. Cocoa fermentation has not yet reached technological maturity, despite the growth in patent documents and scientific research observed in the last two decades. The creation of the Cacao of Excellence Program (2009), among others, has incentivized sustainability and quality in cocoa-producing countries. Brazil, Colombia, and Indonesia are leading with scientific publications in the last 5 years, despite the lack of patents filed. The United Kingdom, France, China, Canada, and Germany, despite not being cocoa-producing countries, are the main holders of the technology. Patent documents analyzed relate to food science, biotechnology, engineering, and chemistry. Microbial biotechnology has gained attention as a key factor to produce a higher-quality cocoa bean. Saccharomyces is the most frequent genus of yeast used as a starter culture in patent documents. Some patent documents propose the addition of fruits during cocoa fermentation, but a few scientific studies have been found on the matter. Overall, technological applications and scientific studies have focused on improving cocoa quality. The cocoa market is expected to increase significantly in the next few years, representing an opportunity to develop high-quality cocoa using novel fermentation techniques. Full article

As official public records of inventions, patents provide an understanding of technological trends across the competitive landscape of various industries. However, traditional manual analysis methods have become increasingly inadequate due to the rapid expansion of patent information and its unstructured nature. This paper contributes an original approach to enhance the understanding of patent data, with connected vehicle (CV) patents serving as the case study. Using free, open-source natural language processing (NLP) libraries, the author introduces a novel metric to quantify the alignment of classifications by a subject matter expert (SME) and using machine learning (ML) methods. The metric is a composite index that includes a purity factor, evaluating the average ML conformity across SME classifications, and a dispersion factor, assessing the distribution of ML assigned topics across these classifications. This dual-factor approach, labeled the H-index, quantifies the alignment of ML models with SME understanding in the range of zero to unity. The workflow utilizes an exhaustive combination of state-of-the-art tokenizers, normalizers, vectorizers, and topic modelers to identify the best NLP pipeline for ML model optimization. The study offers manifold visualizations to provide an intuitive understanding of the areas where ML models align or diverge from SME classifications. The H-indices reveal that although ML models demonstrate considerable promise in patent analysis, the need for further advancements remain, especially in the domain of patent analysis. Full article

Under the premise of resource constraint, it is crucial to identify the product innovation opportunities contained in failed patents through external search in order to compensate for the shortcomings of enterprises’ own technology. Due to the cost of patent research and development and the risk of infringement, this paper constructs a product innovation identification path that integrates the FOS and BERTopic model from the perspective of invalid patents. The path consists of three stages, including the identification of the problem to be solved by the product based on functional analysis, the extraction of the subject matter elements based on the core failed patent technology, and the generation and evaluation of innovative solutions based on TRIZ theory and the best- worst method (BWM). Finally, the feasibility of the path constructed in this paper is verified by taking a slurry pump as an example. The application results show that the product innovation identification path constructed in this paper can provide theoretical support for enterprises to carry out technological innovation activities efficiently. Full article

COVID-19 has had devastating effects worldwide, and vaccines have become the most efficient solution to address the current pandemic situation thus far. After COVID-19 vaccines had been developed, discussions of the various countries’ equality of access gained traction, with patents and pricing forming a significant part of this discourse. Therefore, this study investigates the impact of patents and prices on the accessibility of COVID-19 vaccines in the developing world, using semi-structured interviews with subject-matter experts in this area of focus. Our analysis of these interviews highlights the fact that patents and prices are not the major barriers to accessibility for medical treatments, both generally and specifically in terms of COVID-19; rather, these barriers relate to the lack of local production capacity, technology transfer, infrastructure, local regulations, and supply-chain competencies. These results suggest that rather than focusing on patents and prices, governments should invest more time in improving technology transfer and using compulsory licenses as a negotiation tool. Moreover, the results show that the pricing strategies applied by companies could have different impacts on access, as could accessibility programs such as COVAX. Full article

The selection of biomaterials as biomedical implants is a significant challenge. Ultra-high molecular weight polyethylene (UHMWPE) and composites of such kind have been extensively used in medical implants, notably in the bearings of the hip, knee, and other joint prostheses, owing to its biocompatibility and high wear resistance. For the Anterior Cruciate Ligament (ACL) graft, synthetic UHMWPE is an ideal candidate due to its biocompatibility and extremely high tensile strength. However, significant problems are observed in UHMWPE based implants, such as wear debris and oxidative degradation. To resolve the issue of wear and to enhance the life of UHMWPE as an implant, in recent years, this field has witnessed numerous innovative methodologies such as biofunctionalization or high temperature melting of UHMWPE to enhance its toughness and strength. The surface functionalization/modification/treatment of UHMWPE is very challenging as it requires optimizing many variables, such as surface tension and wettability, active functional groups on the surface, irradiation, and protein immobilization to successfully improve the mechanical properties of UHMWPE and reduce or eliminate the wear or osteolysis of the UHMWPE implant. Despite these difficulties, several surface roughening, functionalization, and irradiation processing technologies have been developed and applied in the recent past. The basic research and direct industrial applications of such material improvement technology are very significant, as evidenced by the significant number of published papers and patents. However, the available literature on research methodology and techniques related to material property enhancement and protection from wear of UHMWPE is disseminated, and there is a lack of a comprehensive source for the research community to access information on the subject matter. Here we provide an overview of recent developments and core challenges in the surface modification/functionalization/irradiation of UHMWPE and apply these findings to the case study of UHMWPE for ACL repair. Full article

Quercetin is a phenolic flavonol compound with established antioxidant, anti-inflammatory, and immuno-stimulant properties. Recent studies demonstrate the potential of quercetin against COVID-19. This article highlighted the prophylactic/therapeutic potential of quercetin against COVID-19 in view of its clinical studies, inventions, and patents. The literature for the subject matter was collected utilizing different databases, including PubMed, Sci-Finder, Espacenet, Patentscope, and USPTO. Clinical studies expose the potential of quercetin monotherapy, and also its combination therapy with other compounds, including zinc, vitamin C, curcumin, vitamin D3, masitinib, hydroxychloroquine, azithromycin, and ivermectin. The patent literature also examines claims that quercetin containing nutraceuticals, pharmaceuticals, and dietary supplements, alone or in combination with other drugs/compounds, including favipiravir, remdesivir, molnupiravir, navitoclax, dasatinib, disulfiram, rucaparib, tamarixin, iota-carrageenan, and various herbal extracts (aloe, poria, rosemary, and sphagnum) has potential for use against COVID-19. The literature reveals that quercetin exhibits anti-COVID-19 activity because of its inhibitory effect on the expression of the human ACE2 receptors and the enzymes of SARS-CoV-2 (MPro, PLPro, and RdRp). The USFDA designated quercetin as a “Generally Recognized as Safe” substance for use in the food and beverage industries. It is also an inexpensive and readily available compound. These facts increase the possibility and foreseeability of making novel and economical drug combinations containing quercetin to prevent/treat COVID-19. Quercetin is an acidic compound and shows metabolic interaction with some antivirals, antibiotics, and anti-inflammatory agents. Therefore, the physicochemical and metabolic drug interactions between quercetin and the combined drugs/compounds must be better understood before developing new compositions. Full article

A combination of 3D printing techniques and synthetic biology, 3D bioprinting is a promising field. It is expected that 3D bioprinting technologies will have applications across an array of fields, spanning biotechnology, medical surgery and the pharmaceutical industry. Nonetheless, the progress of these technologies could be hindered, unless there is adequate and effective protection for related applications. In this article, the authors examine the patent eligibility of 3D bioprinting technologies. This issue raises concern given that existing patent systems are generally averse to nature-derived inventions and many of them exclude products of nature or discoveries from patentability. This qualitative study analyses the current patent systems in key jurisdictions, particularly, the U.S. and the EU, and their applicability, as well as effectiveness, in the context of 3D bioprinting. The study argues that the main reason for the apathy of existing patent systems towards bio-inventions is that they were designed to deal with mechanical inventions. It suggests an innovation framework that encompasses both mechanical and biological inventions to cater adequately to emerging technologies. Full article

The current regulatory landscape that applies to maritime service robotics, aptly termed as robotics and autonomous systems (RAS), is quite complex. When it comes to patents, there are multifarious considerations in relation to vessel survey, inspection, and maintenance processes under national and international law. Adherence is challenging, given that the traditional delivery methods are viewed as unsafe, strenuous, and laborious. Service robotics, namely micro aerial vehicles (MAVs) or drones, magnetic-wheeled crawlers (crawlers), and remotely operated vehicles (ROVs), function by relying on the architecture of the Internet of Robotic Things. The aforementioned are being introduced as time-saving apparatuses, accompanied by the promise to acquire concrete and sufficient data for the identification of vessel structural weaknesses with the highest level of accuracy to facilitate decision-making processes upon which temporary and permanent measures are contingent. Nonetheless, a noticeable critical issue associated with RAS effective deployment revolves around non-personal data governance, which comprises the main analytical focus of this research effort. The impetus behind this study stems from the need to enquire whether “data” provisions within the realm of international technological regulatory (techno-regulatory) framework is sufficient, well organized, and harmonized so that there are no current or future conflicts with promulgated theoretical dimensions of data that drive all subject matter-oriented actions. As is noted from the relevant expository research, the challenges are many. Engineering RAS to perfection is not the end-all and be-all. Collateral impediments must be avoided. A safety net needs to be devised to protect non-personal data. The results here indicate that established data decision dimensions call for data security and protection, as well as a consideration of ownership and liability details. An analysis of the state-of-the-art and the comparative results assert that the abovementioned remain neglected in the current international setting. The findings reveal specific data barriers within the existing international framework. The ways forward include strategic actions to remove data barriers towards overall efficacy of maritime RAS operations. The overall findings indicate that an effective transition to RAS operations requires optimizing the international regulatory framework for opening the pathways for effective RAS operations. Conclusions were drawn based on the premise that policy reform is inevitable in order to push the RAS agenda forward before the emanation of 6G and the era of the Internet of Everything, with harmonization and further standardization being very high priority issues. Full article

Methane production by fermentation is a complex biochemical process, in which micromolecular organic substances are broken down by anaerobic bacteria into simple stabilized chemicals—mainly methane CH₄ and carbon dioxide CO₂. The organic matter of the slurry consists mainly of fats, proteins and carbohydrates. As a result of biochemical changes in the process of anaerobic decomposition, some of this matter is mineralized to simple chemical compounds. Cattle and pig husbandry offers enormous potential for useable biogas plant substrates. As a result of the constantly increasing amounts of animal husbandry products, and increasingly stringent environmental protection requirements aimed at reusing natural fertilizers, it is necessary to look for alternative processing methods. The need for efficiency in obtaining biogas from substrates (e.g., manure) was met by the laboratory stand presented in this article, for which the Polish patent No. 232200 was obtained. The new technology also allows leaching of the organic liquid, e.g., from manure, and subjecting it to methane fermentation. The solution allows the individual elements of the technological line that determine the fermentation process to be tested under laboratory conditions. It also allows testing of the substrates in terms of fermentation, to determine their physical and chemical characteristics, and then to characterize the fermentation process in terms of the quality and quantity of the resulting biogas and the quality of post-fermentation residues. Compressing biogas for local distribution was also proposed. As part of the research, using a laboratory stand, the organic matter was leached from manure, for the purpose of biogas production. In addition, the biogas yield from manure at varying degrees of maturity was assessed. The best properties in terms of biogas yield forecasting were demonstrated by manure composted for 4–8 weeks. Full article

Non-patent literature is defined as scientific publications, technical standards, conference proceedings, clinical trials, books, manuals, technical or research reports, or any other technical scientific material which is cited in patents to show what has already been published and disseminated about the invention to be patented, in order to justify its novelty. These documents are considered technically relevant to the patent granting procedure and are cited along with other patents related to the same subject matter. Full article